Search Results

Vistagen announced today that for the second consecutive year it has been recognized by Mental Health America (MHA) for its dedication to promoting mental health and well-being in the workplace.

Sinaptica Therapeutics, Inc. today announced that it has been selected to join StartUp Health’s Alzheimer’s Moonshot.

GBS Inc., a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, announced it has obtained Institutional Review Board approval to initiate subject enrollment at the Diabetes Research Institute of Sutter Health’s Mills-Peninsula Medical Center in San Mateo, California.

Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authorities

Praia Health, a consumer platform for delivering individualized health solutions at scale, announced today a new partnership with CLEAR, the secure identity company, to enhance identity verification processes for health systems.

23andMe Holding Co. and Nightingale Health Plc announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members.

Fractyl Health, Inc., a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes, announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, will participate in a fireside chat at the upcoming BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT.